Editorial: Optimizing outcomes for children with immune-mediated chronic kidney disease
Thomas Renson,
Thomas Renson,
Evelien Snauwaert,
Evelien Snauwaert,
Lorraine Hamiwka,
Lorraine Hamiwka,
Susa Benseler,
Lovro Lamot,
Lovro Lamot
Affiliations
Thomas Renson
Pediatric Rheumatology, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium
Thomas Renson
European Reference Network for Rare Immunodeficiency, Autoinflammatory, Autoimmune and Pediatric Rheumatic Diseases, Ghent University Hospital, Ghent, Belgium
Evelien Snauwaert
Pediatric Nephrology, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium
Evelien Snauwaert
European Rare Kidney Disease Network, Ghent University Hospital, Ghent, Belgium
Lorraine Hamiwka
Nephrology, Department of Pediatrics, University of Calgary, Calgary, AB, Canada
Lorraine Hamiwka
Cumming School of Medicine, Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada
Susa Benseler
Children’s Health Ireland, Dublin, Ireland
Lovro Lamot
Department of Pediatrics, University of Zagreb School of Medicine, Zagreb, Croatia
Lovro Lamot
Nephrology, Dialysis and Transplantation, Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia
